Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001779990-26-000002

Director acquired 63,227 shares (other)

From the SEC's structured data for this filing

Trades in this filing

HENDERSON MICHAEL THOMAS · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-21 Other acquisition : show line 1 in the form +63,227 168,606 D
Loading xslF345X05/wk-form4_1769221869.xml…